Gnetin C acts through MTA1/ETS2-mediated mechanisms in prostate cancer and shows significant MTA1-mediated inhibitory effects on cell viability, colony formation and migration, and induces cell cycle arrest and cell death at 25 and 50 μM concentrations. The gene discussed is MTA1; the disease is Familial prostate cancer.